Oakmoss Exhibits Antihyperglycemic Activity in Streptozotocin-Induced Diabetic Rats.

Ayoub Amssayef, Ismail Bouadid, Mohamed Eddouks
{"title":"Oakmoss Exhibits Antihyperglycemic Activity in Streptozotocin-Induced Diabetic Rats.","authors":"Ayoub Amssayef, Ismail Bouadid, Mohamed Eddouks","doi":"10.2174/1871529X22666220316100022","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>The study aimed to assess the antidiabetic effect of Oakmoss.</p><p><strong>Background: </strong>Lichens species are dual organisms consisting of a mycobiont (Fungi) and a photoautotrophic partner (Algae). They are widely used in traditional medicine as a treatment against diabetes.</p><p><strong>Objective: </strong>This study was designed to assess the antihyperglycemic activity as well as the antihyperlipidemic capacity of Oakmoss (Evernia prunastri (L.)) in normal and streptozotocin(STZ)-induced diabetic rats.</p><p><strong>Methods: </strong>This study has evaluated the effects of aqueous extract of Oakmoss at a dose of 60 mg/kg on blood glucose levels and lipid profile in normal and STZ-induced diabetic rats. Histopathological examination of liver, determination of glycogen content in liver and skeletal muscles (EDL and soleus), antioxidant activity, and phytochemical investigation were also performed.</p><p><strong>Results: </strong>Both single and repeated oral doses of Oakmoss (60 mg/kg) produced a significant reduction of blood glucose, triglycerides and very low-density lipoprotein (VLDL) levels in diabetic rats. Furthermore, repeated oral administration of Oakmoss during 7 days ameliorated the liver function by increasing its glycogen content and improving its histological architecture in treated diabetic rats. In addition, the aqueous extract of Oakmoss exhibited an antioxidant activity and showed richness in certain phytochemicals especially in phenolic acids and flavonoids.</p><p><strong>Conclusion: </strong>Oakmoss, a lichen species, exhibits a potential effect on improving hyperglycemia and hypertriglyceridemia in diabetic rats.</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular & hematological disorders drug targets","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1871529X22666220316100022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: The study aimed to assess the antidiabetic effect of Oakmoss.

Background: Lichens species are dual organisms consisting of a mycobiont (Fungi) and a photoautotrophic partner (Algae). They are widely used in traditional medicine as a treatment against diabetes.

Objective: This study was designed to assess the antihyperglycemic activity as well as the antihyperlipidemic capacity of Oakmoss (Evernia prunastri (L.)) in normal and streptozotocin(STZ)-induced diabetic rats.

Methods: This study has evaluated the effects of aqueous extract of Oakmoss at a dose of 60 mg/kg on blood glucose levels and lipid profile in normal and STZ-induced diabetic rats. Histopathological examination of liver, determination of glycogen content in liver and skeletal muscles (EDL and soleus), antioxidant activity, and phytochemical investigation were also performed.

Results: Both single and repeated oral doses of Oakmoss (60 mg/kg) produced a significant reduction of blood glucose, triglycerides and very low-density lipoprotein (VLDL) levels in diabetic rats. Furthermore, repeated oral administration of Oakmoss during 7 days ameliorated the liver function by increasing its glycogen content and improving its histological architecture in treated diabetic rats. In addition, the aqueous extract of Oakmoss exhibited an antioxidant activity and showed richness in certain phytochemicals especially in phenolic acids and flavonoids.

Conclusion: Oakmoss, a lichen species, exhibits a potential effect on improving hyperglycemia and hypertriglyceridemia in diabetic rats.

橡树苔对链脲佐菌素诱导的糖尿病大鼠具有降血糖活性
目的:本研究旨在评估橡树苔的抗糖尿病作用:背景:地衣物种是由真菌和藻类组成的双重生物。它们在传统医学中被广泛用作治疗糖尿病的药物:本研究旨在评估橡树苔(Evernia prunastri (L.))对正常大鼠和链脲佐菌素(STZ)诱导的糖尿病大鼠的降血糖活性和降血脂能力:本研究评估了剂量为 60 mg/kg 的橡树苔水提取物对正常大鼠和 STZ 诱导的糖尿病大鼠血糖水平和血脂谱的影响。此外,还进行了肝脏组织病理学检查、肝脏和骨骼肌(EDL 和比目鱼肌)糖原含量测定、抗氧化活性和植物化学调查:结果:单次和多次口服橡树苔(60 毫克/千克)均能显著降低糖尿病大鼠的血糖、甘油三酯和极低密度脂蛋白(VLDL)水平。此外,在 7 天内重复口服橡树苔可通过增加糖原含量和改善组织结构来改善糖尿病大鼠的肝功能。此外,橡树苔的水提取物还具有抗氧化活性,并富含某些植物化学物质,尤其是酚酸和类黄酮:结论:地衣物种橡树苔对改善糖尿病大鼠的高血糖和高甘油三酯血症有潜在作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信